Prospective, Multicenter, Single-arm, Open-label Study to Assess the Safety and Feasibility of the Levita Magnetic Surgical System for Reduced Port in Upper Gastrointestinal Laparoscopic Procedures
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 30
- 试验地点
- 2
- 主要终点
- Number of Participants with Device and/or Procedure Related Adverse Events
研究概览
简要总结
A Study at Multiple Centers to Evaluate the Safety and Practicality of the Levita Magnetic Surgical System for Use in Laparoscopic Upper Gastrointestinal Surgeries.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Other
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •BMI range of 20 to 60kg/m2
- •Scheduled to undergo laparoscopic procedures
- •Willing and able to provide a written Informed Consent Form (ICF) to participate in the study prior to any study- required procedures
排除标准
- •Individuals with pacemakers, defibrillators, or other electromedical implants
- •Individuals with ferromagnetic implants
- •American Society of Anesthesiologists (ASA) score of III or IV
- •Significant comorbidities: cardiovascular, neuromuscular, chronic obstructive pulmonary disease, and urological disease (renal failure)
- •Clinical history of impaired coagulation confirmed by abnormal blood tests
- •Individuals who have signs of hepatic abnormality (e.g.: cirrhosis, liver failure, increase in liver enzymes, etc.)
- •Anatomical abnormality or disease of intended target tissue noted after initiation of index procedure that would prevent device use
- •Pregnant or wishes to become pregnant during the length of study participation
- •Individual is not likely to comply with the follow-up evaluation schedule
- •Participating in a clinical trial of another investigational drug or device
- •Prisoner or under incarceration
研究组 & 干预措施
Magnetic Surgical System in laparoscopic upper gastrointestinal procedures
干预措施: Levita Magnetic Surgical System (Device)
结局指标
主要结局
Number of Participants with Device and/or Procedure Related Adverse Events
时间窗: From enrollment to end of follow up at 30 days.
Adverse events will be summarized by relatedness to the device and/or procedure, seriousness and level of severity.
Average Number of Ports
时间窗: During index procedure.
Ability to adequately retract the stomach, omentum, and small bowel to achieve effective exposure of the target tissue. Adequate retraction will be deemed to be achieved if an additional port that is typically used for retraction and exposure of target tissues can be eliminated.
次要结局
未报告次要终点